PEPG PEPG
Company Profile ↓Company Overview
PEPG (PEPG) is a publicly traded company listed on with a market capitalization of $136.37M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.12.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +48.87% |
| 6 Months: | -63.06% |
| 3 Months: | +2.59% |
| 1 Month: | -3.41% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)52.01 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 72.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 31.32M | 23.93M | 18.65M | 19.70M | 18.94M |
| Operating Income | -6.63M | -5.19M | -8.08M | -13.89M | -17.64M | -19.55M | -18.03M | -21.14M | -24.78M | -19.80M | -30.43M | -23.17M | -31.32M | -23.93M | -18.65M | -19.70M | -18.94M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | -30.00M | -22.66M | -17.38M | -18.43M | -17.69M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | -30.20M | -23.09M | -18.03M | -18.29M | -17.75M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 49.00K | 15.00K |
| Net Income | -6.64M | -5.39M | -8.11M | -18.25M | -17.32M | -18.61M | -16.32M | -19.52M | -23.29M | -18.02M | -28.34M | -21.38M | -30.20M | -23.09M | -18.03M | -18.34M | -17.76M |
| Diluted EPS | - | -6.03 | -9.07 | -18.94 | -1.23 | -0.79 | -0.69 | -0.82 | -0.98 | -0.63 | -0.87 | -0.66 | -0.92 | -0.70 | -0.52 | -0.27 | -0.26 |
| R&D Expense | 5.53M | 3.22M | 5.71M | 10.71M | 14.24M | 15.96M | 14.36M | 16.93M | 20.54M | 14.73M | 25.06M | 17.72M | 25.38M | 18.39M | 13.42M | - | 13.00M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 68.30M | 84.77M | 97.74M | 93.61M |
| Operating Income | - | -68.30M | -84.77M | -97.74M | -93.61M |
| EBITDA | - | -67.81M | -83.92M | -92.49M | -88.47M |
| Interest Expense | - | - | - | - | - |
| Pretax Income | - | -65.40M | -78.55M | -90.60M | -89.61M |
| Tax Provision | - | 3.71M | 73.00K | -617.00K | 49.00K |
| Net Income | - | -69.10M | -78.63M | -89.98M | -89.66M |
| Diluted EPS | - | -2.91 | -3.30 | -2.85 | -2.12 |
| R&D Expense | 19.00M | 54.08M | 68.13M | 76.48M | 71.04M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | - | - | 217.44M | 143.05M | 150.88M | 173.91M |
| Current Assets | - | - | 186.08M | 112.68M | 123.76M | 150.96M |
| Cash & Equivalents | - | - | 181.75M | 80.77M | 49.42M | 60.51M |
| Inventory | - | - | - | - | - | - |
| Receivables | - | 4.74M | 58.00K | - | - | - |
| Total Liabilities | - | - | 37.81M | 34.63M | 32.26M | 26.46M |
| Current Liabilities | - | - | 18.83M | 17.53M | 16.70M | 12.65M |
| Long Term Debt | - | - | - | - | - | - |
| Total Debt | - | - | 24.53M | 20.10M | 18.66M | 17.00M |
| Total Equity | -6.36M | - | 179.63M | 108.42M | 118.62M | 147.44M |
| Shares Outstanding | - | - | 23.71M | 23.82M | 32.62M | 68.87M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -59.27M | -69.00M | -82.37M | -81.64M |
| Investing Cash Flow | - | -3.75M | -32.00M | -37.67M | -15.23M |
| Financing Cash Flow | - | 112.19M | -189.00K | 88.75M | 107.98M |
| Capital Expenditure | - | -3.75M | -2.60M | -497.00K | -264.00K |
| Free Cash Flow | - | -63.02M | -71.60M | -82.87M | -81.90M |
| Net Change in Cash | - | 49.17M | -101.19M | -31.29M | 11.11M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | - | - | - | - |
| ROE % | - | -38.5% | -72.5% | -75.9% | -60.8% |
| ROCE % | - | -34.4% | -67.5% | -72.8% | -58.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PEPG
PepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
PepGen (PEPG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the sto…
Is PepGen (PEPG) One of the Best NASDAQ Stocks Under $5 to Buy Right Now?
PepGen Inc. (NASDAQ:PEPG) is one of the best NASDAQ stocks under $5 to buy right now. On May 12, PepGen reported Q1 2026 financial results, recording a net loss of $17.8 million, or $0.26 per share, compared to a net loss of $30.2 million f…
PepGen (PEPG) Upgraded to Buy: Here's What You Should Know
PepGen (PEPG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AstronauTx builds executive team with appointment of experienced clinical development leader Michelle Mellion, MD as Chief Medical Officer
Brings more than 20 years of neurology, clinical development, and translational experience as AstronauTx prepares to advance its lead programmes into clinical developmentAstronauTx also appoints Deb Gouveia as Vice President, Clinical Opera…
PepGen Reports Encouraging Phase II FREEDOM2 DM1 Data at 5 mg/kg; 10 mg/kg Cohort Underway
PepGen (NASDAQ:PEPG) reported top-line results from the lowest-dose cohort of its Phase II FREEDOM2 multiple ascending dose (MAD) study evaluating PGN-EDO-DM1 in myotonic dystrophy type 1 (DM1), highlighting what management characterized as…
PepGen muscular dystrophy drug gets ‘surprise’ hold from FDA
The agency acted after reviewing mouse data submitted in 2024, making the timing of the new pause “confusing,” one analyst wrote.
PEPG — Frequently Asked Questions
What is the current share price of PEPG?
As of 2026-08-05 17:25 PDT, PEPG trades at $1.98 on NASDAQ/NYSE. Its 52-week range is $1.01 to $7.17.
What is the market capitalisation of PEPG?
PEPG has a market capitalisation of $136.37M on NASDAQ/NYSE.
What is the P/E ratio of PEPG?
PEPG trades at a trailing price-to-earnings (P/E) ratio of -0.93. Its price-to-book (P/B) ratio is 0.92.
What is the return on equity (ROE) of PEPG?
PEPG has a return on equity (ROE) of -60.81%. Its return on capital employed (ROCE) is -58.05%.
Is PEPG a good stock to buy?
This page provides a data-driven analysis of PEPG, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.